BioInvent, Cantargia partner to manufacture myocarditis drug CAN10
BioInvent will receive up to 3.52m for the development, scale-up, supply of material for toxicological studies and clinical…
Lilly, Precision BioSciences enter into genome editing research collaboration
23 Nov 20The research collaboration will leverage ARCUS genome editing technology, and initially include three gene targets
Samsung Biologics, GeneQuantum to co-develop ADC for cancer treatment
02 Nov 20Collaboration with GeneQuantum follows Samsung Biologics' recent partnership with China-based biotech company APRINOIA Therapeutics
Novartis, Molecular Partners to co-develop two anti-Covid-19 DARPin therapies
29 Oct 20Molecular Partners will receive an upfront payment of $65.97m, and an additional payment of $164.93m after the option…
CStone to out-license sugemalimab and CS1003 rights to EQRx
28 Oct 20CStone’s licencing agreement enables EQRx to develop and commercialise the two late-stage immuno-oncology drugs outside of Greater China
Takeda signs collaboration, licensing agreement with Arrowhead for liver disease treatment
09 Oct 20Takeda to make an upfront payment of $300m and up to $740m to Arrowhead as potential milestone payments
Lygos, Open Book Extracts partner to develop CBG-based nutraceuticals
07 Oct 20OBX and Lygos will combine their technologies to produce cannabinoid and cannabinoid-based products at industrial scale
Fujifilm agrees to manufacture VLP Therapeutics’ Covid-19 vaccine
01 Oct 20VLP Therapeutics’ Covid-19 vaccine is said to be a self-amplifying RNA vaccine that leverages lipid nanoparticle formulation, a…
Samsung Biologics, AstraZeneca enter into global supply partnership
22 Sep 20Samsung Biologics will offer large-scale commercial manufacturing in its Plant 3 along with drug product to support AstraZeneca's…
Sanofi, GSK to supply 300 million doses of Covid-19 vaccine to EU
21 Sep 20The potential Covid-19 vaccine candidate leverages Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant technology